Compared to the healthy controls, although there were no obvious differences in risk factors between HER2‐low and HER2‐zero BC among HR‐positive BC, there were subtle differences in subtype‐specific risk factors among HR‐negative BC. Here, ERBB2 is linked to breast cancer.